These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15529592)

  • 1. Aldosterone and cardiovascular pathology: from bench to bedside.
    Vintilă M; Băluţă M
    Rom J Intern Med; 2004; 42(1):15-26. PubMed ID: 15529592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoids and cardiovascular diseases. Status of knowledge from experimental and clinical studies.
    Pasquale PD; Stefano GD; Paterna S
    Ital Heart J; 2000 Sep; 1(9):595-604. PubMed ID: 11130838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aldosterone].
    Tanabe A; Tsuiki M; Watanabe D; Takagi S; Takano K; Naruse M
    Rinsho Byori; 2004 Aug; 52(8):704-10. PubMed ID: 15478626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA; Wendt C; Saborowski F
    Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurohormones and heart failure: the importance of aldosterone.
    Odedra K; Ferro A
    Int J Clin Pract; 2006 Jul; 60(7):835-46. PubMed ID: 16846401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aldosterone as an endogenous cardiovascular toxin and the options for its therapeutic management].
    Horký K
    Vnitr Lek; 2011 Dec; 57(12):1012-6. PubMed ID: 22277034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding view of aldosterone action, with an emphasis on rapid action.
    Vinson GP; Coghlan JP
    Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):410-6. PubMed ID: 20409082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aldosterone and cardiovascular diseases, more than water and salt retention].
    Duprez D
    Verh K Acad Geneeskd Belg; 2002; 64(3):225-32. PubMed ID: 12238244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
    Lim S
    Acta Med Indones; 2008 Jan; 40(1):34-7. PubMed ID: 19054878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of aldosterone and post-acute myocardial infarction pathophysiology.
    Cohn JN; Colucci W
    Am J Cardiol; 2006 May; 97(10A):4F-12F. PubMed ID: 16698330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Involvement of Aldosterone and mineralocorticoid receptor in pathogenesis of cardiovascular diseases].
    Miyamori I
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():144-6. PubMed ID: 15171358
    [No Abstract]   [Full Text] [Related]  

  • 14. Aldosterone blockade over and above ACE-inhibitors in patients with coronary artery disease but without heart failure.
    Shah NC; Pringle S; Struthers A
    J Renin Angiotensin Aldosterone Syst; 2006 Mar; 7(1):20-30. PubMed ID: 17083070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.
    Duprez DA
    J Hypertens; 2006 Jun; 24(6):983-91. PubMed ID: 16685192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of disease: local renin-angiotensin-aldosterone systems and the pathogenesis and treatment of cardiovascular disease.
    Re RN
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):42-7. PubMed ID: 16265259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of high salt intake and the response of the cardiovascular system to aldosterone.
    Conlin PR
    Cardiol Rev; 2005; 13(3):118-24. PubMed ID: 15831143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.
    Jaffe IZ; Mendelsohn ME
    Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H; Gilbert RE
    J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Weber MA
    Am J Cardiol; 2007 Aug; 100(3A):45J-52J. PubMed ID: 17666198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.